Advertisement

Pharmacy World & Science

, Volume 32, Issue 5, pp 546–548 | Cite as

Implementing pharmacy practice research programs for the management of heart failure

  • Michael D. MurrayEmail author
Conference Commentary

Abstract

It stands to reason that pharmacists would have a benefic role in the treatment of patients with chronic illnesses wherein complicated pharmacotherapies are required to reduce the risk of acute exacerbation. For chronic heart failure, recent evidence bears this out. When pharmacists take time to provide self-care instructions for patients with heart failure or take part in collaborative healthcare teams, the need for costly urgent healthcare decreases with corresponding decreases in healthcare costs. Further research is needed to address the key supportive roles of pharmacists in the treatment of patients with heart failure.

Keywords

Pharmacist Practice models Heart failure Treatment adherence Health literacy 

Notes

Conflicts of interest

None.

References

  1. 1.
    Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HGM. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study. J. Cardiac Failure. 2003;9(5):404–11.CrossRefGoogle Scholar
  2. 2.
    Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714–25.PubMedGoogle Scholar
  3. 3.
    Tsuyuki RT, Fradette M, Johnson JA, et al. A multicenter disease management program for hospitalized patients with heart failure. J. Cardiac Failure. 2004;10(6):473–80.CrossRefGoogle Scholar
  4. 4.
    Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: Long-term implications on readmission and survival. Circulation. 2002;105:2861–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med. 2005;165(11):1311; author reply 1311-1312.Google Scholar
  6. 6.
    Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacist’s role. Pharmacotherapy. 2007;27(4 Pt 2):18S–28S.CrossRefPubMedGoogle Scholar
  7. 7.
    Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757–63.CrossRefPubMedGoogle Scholar
  8. 8.
    Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 2003;89(6):605–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158(10):1108–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther. 2009;85(6):651–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Purdue University College of PharmacyWest LafayetteUSA
  2. 2.Regenstrief InstituteIndianapolisUSA

Personalised recommendations